Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001144204-17-003608

Director acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Runge Jeffrey W. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-01-20 Exercise or conversion : show line 1 in the form +20,000 $3.11 $62,200 197,700 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-01-20 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −20,000 0 D
Loading xslF345X03/v457389_4.xml…